Most drugs, hormones and xenobiotics are metabolized by human and animal bodies into hydrophilic molecules and then quickly excreted in body fluids, mainly urine. Those conjugated drugs and molecules are mainly conjugated with glucuronides or sulfates (glucuronogonjugates and sulfoconjugates). In humans, glucuronidation is the main phase II metabolic pathway. Conjugates are difficult to detect and quantitate by chromatographic instruments, gas chromatography (GCMS), and liquid chromatography (LCMS). Hydrolysis with Beta-glucuronidase and/or sulfatase cleaves conjugated bonds and reverts drugs, hormones, and xenobiotics back into their initial free form. Freed analytes are easily “visible” and measurable by laboratory instruments for screening or quantitation.
Beta-glucuronidase enzymes have been available to the life-science and diagnostic industries for over five decades, primarily extracted from the entrails of different animals (Helix pomatia or Haliotis __ rufescens), or bacterial sources (Escherichia coli). Since 2015, there has been a shift to recombinant beta-glucuronidases in analytical toxicology and routine urine drug testing. Due to improved analytical quality, ease of sample preparation, reduced incubation time, and automation capacity, our recombinant beta-glucuronidase enzymes (SRE0093, SRE0095) are increasingly being used across multiple application fields as an analytical enzyme.
Urine Drug Testing (UDT) is the main routine application for beta-glucuronidase and sulfatase. The enzymes used in UDT applies to different types of testing:
Recent instrumentation advancements enable direct detection of glucuronides and sulfates. However, hydrolysis is still preferred or required by most research or routine laboratories for many reasons:
Our sites have been manufacturing native and recombinant beta-glucuronidases since 1960. All our beta-glucuronidases and arylsulfatase are produced within the ISO9001 quality system. We continue to dedicate our effort in making hydrolysis quicker, easier to implement, and ready-to-use.
Investigación. Desarrollo. Producción.
Somos un proveedor líder para la industria de Ciencias de la Vida con soluciones y servicios para investigación, desarrollo y producción biotecnológicos, y para desarrollo y producción de tratamientos farmacéuticos
© 2021 Merck KGaA, Darmstadt, Alemania y/o sus filiales. Todos los derechos reservados.